Acadian Asset Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Acadian Asset Management’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-108,518	Closed	-$335K	–	1906
2021 Q4	$335K	Sell	108,518 -50,791	-32%	-$171K	﹤0.01%	1113
2021 Q3	$573K	Buy	+159,309	New	+$601K	﹤0.01%	1004
2019 Q4	–	Sell	-58,243	Closed	-$245K	–	2193
2019 Q3	$245K	Hold	58,243	–	–	﹤0.01%	1270
2019 Q2	$271K	Buy	58,243 +45,269	+349%	+$211K	﹤0.01%	1154
2019 Q1	$69K	Buy	12,974 +225	+2%	+$1.03K	﹤0.01%	1609
2018 Q4	$48K	Buy	12,749 +2,303	+22%	+$8.09K	﹤0.01%	1434
2018 Q3	$29K	Buy	+10,446	New	+$29.3K	﹤0.01%	1463
2017 Q2	–	Sell	-35,405	Closed	-$67K	–	1765
2017 Q1	$67K	Sell	35,405 -31,872	-47%	-$61.5K	﹤0.01%	1188
2016 Q4	$118K	Sell	67,277 -12,706	-16%	-$26K	﹤0.01%	1080
2016 Q3	$217K	Buy	+79,983	New	+$203K	﹤0.01%	955
2016 Q2	–	Sell	-34,556	Closed	-$111K	–	1648
2016 Q1	$111K	Buy	+34,556	New	+$128K	﹤0.01%	1007

Other funds holding BDSI

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

FCMT

Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

Acadian Asset Management's BDSI Position: Q1 2022 in Review

Acadian Asset Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 108,518 shares — an estimated $335K sold.

Acadian Asset Management first reported a position in BDSI in Q1 2016 and held it in 11 quarters. The position peaked at $573K in Q3 2021. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

Acadian Asset Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
Acadian Asset Management sold 108,518 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $335K.
Acadian Asset Management first reported a position in BioDelivery Sciences International, Inc. in Q1 2016 and held it in 11 quarters.
Acadian Asset Management's BioDelivery Sciences International, Inc. position peaked at $573K in Q3 2021.
2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Acadian Asset Management's 13F filing for Q1 2022, filed 12 May 2022.